Top compounds associated with response to AC016753.1


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.03
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.03
mRNA thalidomide CTRPv2 pan-cancer AAC 0.11 0.04
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.069 0.04
mRNA Platin CTRPv2 pan-cancer AAC 0.076 0.04
mRNA BRD-K09587429 CTRPv2 pan-cancer AAC 0.08 0.04
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.05
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.05
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.085 0.06
mRNA ML320 CTRPv2 pan-cancer AAC -0.065 0.06
Download CSV